Search company, investor...

Plurogen Therapeutics

plurogen.com

Founded Year

2003

Stage

Series B - III | Alive

Total Raised

$6.38M

Last Raised

$150K | 9 yrs ago

About Plurogen Therapeutics

PluroGen Therapeutics provides clinically advanced and advantaged burn, wound and skin care products. The company works closely with doctors, nurses, patients and healthcare institutions to provide the best products for burn, wound and skin care to help people have a better quality of life. The Company's primary platform is its core PluroGel surfactant technology which provides products with paradigm-shifting, superior and differentiated Core, Bio-Physical, and Performance Functions resulting in unique and advantaged Multi-Function products.

Headquarters Location

2495 General Armistead Ave

Norristown, Pennsylvania, 19403,

United States

610-539-3670

Missing: Plurogen Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Plurogen Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Plurogen Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Plurogen Therapeutics is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Plurogen Therapeutics Patents

Plurogen Therapeutics has filed 7 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/20/2016

10/29/2019

Bacteriology, Antibiotics, Inflammations, Microbiology, Immune system

Grant

Application Date

1/20/2016

Grant Date

10/29/2019

Title

Related Topics

Bacteriology, Antibiotics, Inflammations, Microbiology, Immune system

Status

Grant

Latest Plurogen Therapeutics News

PluroGen Therapeutics Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Dec 6, 2016

PluroGen Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 18:07 EST 6 Dec 2016 | BioPortfolio Reports Home » Topics » Biotechnology Business » Latest News » PluroGen Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PluroGen Therapeutics, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by PluroGen Therapeutics, Inc. since January 2007. Key Findings Provides intelligence on PluroGen Therapeutics, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by PluroGen Therapeutics, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for PluroGen Therapeutics, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about PluroGen Therapeutics, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

Plurogen Therapeutics Frequently Asked Questions (FAQ)

  • When was Plurogen Therapeutics founded?

    Plurogen Therapeutics was founded in 2003.

  • Where is Plurogen Therapeutics's headquarters?

    Plurogen Therapeutics's headquarters is located at 2495 General Armistead Ave, Norristown.

  • What is Plurogen Therapeutics's latest funding round?

    Plurogen Therapeutics's latest funding round is Series B - III.

  • How much did Plurogen Therapeutics raise?

    Plurogen Therapeutics raised a total of $6.38M.

  • Who are the investors of Plurogen Therapeutics?

    Investors of Plurogen Therapeutics include Virginia Active Angel Network (VAAN), Jefferson Corner Group, Cato BioVentures, Tall Oaks Capital and Batten Institute at the Darden School.

  • Who are Plurogen Therapeutics's competitors?

    Competitors of Plurogen Therapeutics include OcuNexus Therapeutics, Adhezion Biomedical, Carena, Anacor Pharmaceuticals, Revance Therapeutics and 11 more.

Compare Plurogen Therapeutics to Competitors

O
OcuNexus Therapeutics

OcuNexus Therapeutics is a development stage biopharmaceutical company that develops treatments for front- and back-of-the-eye diseases and disorders.

D
DermAvance Pharmaceuticals

DermAvance Pharmaceuticals, a pharmaceutical company engaged in advanced technology applications for skin health and cosmetic dermatology, announced the acquisition of the North American rights for the Hyalogy Total Skin Care Line from Forlle'd in Japan.

A
Adhezion Biomedical

Adhezion Biomedical is a medical device company focused on the development and commercialization of cyanoacrylate-based surgical, wound management and infection prevention technologies for use in professional and consumer healthcare settings.

T
Total Pharmaceutical Care

Total Pharmaceutical Care, Inc. offers home healthcare and infusion therapy services

B
Biofisica

Biofisica develops and markets products for soft tissue wound healing and tissue regeneration based on an exclusive and technology that uses electrical stimulation and hydro-gel materials.

A
Aero Pharmaceuticals

Aero Pharmaceuticals, Inc markets lines of dermatological products under Baker Cummins Dermatologicals. Baker Cummins Dermatologicals markets a line of scalp and skin care products that can be used to treat dry skin and scalp conditions commonly seen.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.